Tuesday February 9, 2010 9:18 PM ET
SmartMoney
Share Price ($): 
36.47
Price Change: 
-0.12 (-0.33%)
Last 10 Quotes
What is this?
MRK 
(Merck & Co. Inc.)
Exchange: NYSE     Industry: Drug Manufacturers/Major
Last Trade 4:01 PM ET 2/9/2010
Click Here Click Here
Volume:17,143,288
Day's Low:$36.32
52-wk Low:$31.25
Previous Close:$36.59
Dividend:$0.38
Market Cap:113,394,900
Avg Volume: 15,090,500
Day's High:$37.17
52-wk High:$41.56
Open Price:$36.93
Yield: 4.15%
P/E (Forward): 10.58
Chart for MRK
After-Hours Trading:
Last Trade:6:57 PM
Price:36.60
Volume:100
Breaking News
11:35 AM  2/9/2010   UPDATE: Biogen 4Q Profit Up 48%; Offers Bright 2010 Forecast
9:20 AM  2/9/2010   Biogen: Heart Drug Data Doesn't Support Continued Development
4:09 PM  2/5/2010   Sanofi Nears Decision On Combining Animal Unit With Merck's
12:44 PM  2/4/2010   Merck Delays Return Of ProQuad Childhood Vaccine
4:20 PM  2/3/2010   MARKET SNAPSHOT: U.S. Stocks Snap Win-streak As Health Shares Drop
3:45 PM  2/3/2010   MARKET SNAPSHOT: U.S. Stocks Head For Lower Close
2:46 PM  2/3/2010   MARKET SNAPSHOT: U.S. Stocks Falter As Earnings Reports Fall Short
Stories & Blogs: Around the Web
2/9/2010  Pfizer Off 2% As 2010 Targets Miss; Posts Revised 2012 Targets (Barrons.com)
2/9/2010  McGinn Likes Ford, Citi, Merck, Pfizer (Barrons.com)
2/9/2010  Investors Seek More Disclosure on Political Spending (WSJ.com)
2/9/2010  Republicans and Democrats will debate on TV, but little may come of it. (The Motley Fool)
2/9/2010  Or at least take a moment to read this first! (The Motley Fool)
2/9/2010  Amgen's Prolia passes another test on its way to potential blockbuster status. (The Motley Fool)
2/9/2010  Dividends are great, but dividends that the rest of the market overlooks can be even better. (The Motley Fool)
2/9/2010  Tysabri Boosts Biogen Earnings (WSJ.com)
Earnings & Forecast
Most Recent Quarter ($)Same Quarter Last Year ($)% Change
EPS, Pro Forma 0.90 0.80 12.50
EPS, GAAP 0.29 0.51 -43.14
Consensus Estimate 0.82 0.79 3.80
Trailing 12 MonthsYear-Earlier Period% Change
EPS, Pro Forma 3.34 3.42 -2.34
EPS, GAAP 1.91 2.10 -9.05
Consensus Estimate 3.11 NA NA
Key Statistics
MRKIndustry Average
P/E (TTM) 19.16 14.70
P/E (Forward) 10.58 12.60
PEG Ratio 2.41 1.45
Price/Sales 3.08 2.51
Beta 0.88 0.88
Advertisements
View Overview for: